M.D.C. Holdings, Inc. (NYSE:MDC) Director Herbert T. Buchwald sold 4,644 shares of the business’s stock in a transaction dated Tuesday, March 13th. The shares were sold at an average price of $29.84, for a total transaction of $138,576.96. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Herbert T. Buchwald also recently made the following trade(s):
- On Friday, December 15th, Herbert T. Buchwald sold 28,350 shares of M.D.C. stock. The shares were sold at an average price of $31.52, for a total transaction of $893,592.00.
M.D.C. Holdings, Inc. (NYSE:MDC) traded down $0.90 during mid-day trading on Wednesday, hitting $28.80. 222,397 shares of the company’s stock were exchanged, compared to its average volume of 804,424. M.D.C. Holdings, Inc. has a 12-month low of $26.94 and a 12-month high of $37.45. The company has a debt-to-equity ratio of 0.78, a current ratio of 10.01 and a quick ratio of 3.34. The stock has a market capitalization of $1,587.73, a PE ratio of 10.66, a price-to-earnings-growth ratio of 0.60 and a beta of 1.47.
The business also recently declared a quarterly dividend, which was paid on Wednesday, February 21st. Investors of record on Wednesday, February 7th were given a dividend of $0.30 per share. The ex-dividend date of this dividend was Tuesday, February 6th. This represents a $1.20 annualized dividend and a dividend yield of 4.17%. This is a boost from M.D.C.’s previous quarterly dividend of $0.25. M.D.C.’s payout ratio is currently 48.10%.
Several hedge funds and other institutional investors have recently made changes to their positions in MDC. Crossmark Global Holdings Inc. purchased a new position in shares of M.D.C. during the third quarter valued at about $571,000. American Century Companies Inc. increased its position in shares of M.D.C. by 50.0% during the third quarter. American Century Companies Inc. now owns 200,725 shares of the construction company’s stock valued at $6,666,000 after buying an additional 66,905 shares during the period. Prudential Financial Inc. increased its position in shares of M.D.C. by 90.6% during the third quarter. Prudential Financial Inc. now owns 583,941 shares of the construction company’s stock valued at $19,393,000 after buying an additional 277,580 shares during the period. Principal Financial Group Inc. increased its position in shares of M.D.C. by 21.5% during the third quarter. Principal Financial Group Inc. now owns 492,443 shares of the construction company’s stock valued at $16,354,000 after buying an additional 87,183 shares during the period. Finally, BNP Paribas Arbitrage SA increased its position in shares of M.D.C. by 76.1% during the third quarter. BNP Paribas Arbitrage SA now owns 23,767 shares of the construction company’s stock valued at $789,000 after buying an additional 10,269 shares during the period. Institutional investors own 94.24% of the company’s stock.
MDC has been the topic of a number of analyst reports. UBS Group restated a “sell” rating and issued a $32.00 price objective (up previously from $30.00) on shares of M.D.C. in a research report on Wednesday, January 17th. Zacks Investment Research upgraded shares of M.D.C. from a “hold” rating to a “strong-buy” rating and set a $38.00 price objective on the stock in a research report on Thursday, February 1st. Bank of America boosted their price objective on shares of M.D.C. from $31.00 to $34.00 and gave the company an “underperform” rating in a research report on Friday, February 2nd. Raymond James Financial upgraded shares of M.D.C. from a “market perform” rating to an “outperform” rating and set a $35.00 price objective on the stock in a research report on Tuesday, February 13th. They noted that the move was a valuation call. Finally, ValuEngine cut shares of M.D.C. from a “buy” rating to a “hold” rating in a research report on Thursday, March 1st. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $33.71.
M.D.C. Company Profile
M.DC Holdings, Inc is engaged in two primary operations, including homebuilding and financial services. The Company’s segments include West, including segments located in Arizona, California, Nevada and Washington; Mountain, including segments located in Colorado and Utah; East, including segments located in Virginia, Florida and Maryland, which includes Pennsylvania and New Jersey; mortgage operations, including HomeAmerican Mortgage Corporation, and Other, which includes Allegiant Insurance Company, Inc, StarAmerican Insurance Ltd., American Home Insurance Agency, Inc and American Home Title and Escrow Company.
Receive News & Ratings for M.D.C. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M.D.C. and related companies with MarketBeat.com's FREE daily email newsletter.